Gould Robert J (CIK 0001577034)

Latest company ownership

FULC - Fulcrum Therapeutics, Inc.

Role: Director

Shares held

484,864

Last filed at

Nov 21, 2025

Confidence Score

41.6

2025Q4

Confidence Score History

2020Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 19, 2025	Nov 21, 2025	Fulcrum Therapeutics, Inc.	Director	Sell	37.5	-15,000	-3.00%	✓	$165.5K
Jan 13, 2023	Jan 13, 2023	Fulcrum Therapeutics, Inc.	CEO	Sell	45.0	-6,766	-1.34%	✓	$101.5K
Jun 7, 2022	Jun 8, 2022	Fulcrum Therapeutics, Inc.	Director	Sell	22.5	-71,435	-12.36%	✓	$577.9K
Jun 2, 2022	Jun 6, 2022	Fulcrum Therapeutics, Inc.	Director	Sell	35.0	-66,622	-4.20%	✓	$532.8K
Apr 7, 2022	Apr 11, 2022	Fulcrum Therapeutics, Inc.	Director	Sell	45.0	-5,631	-1.10%	✓	$135.2K
Apr 1, 2022	Apr 5, 2022	Fulcrum Therapeutics, Inc.	Director	Sell	27.5	-94,251	-5.84%	✓	$2.3M
Mar 15, 2021	Mar 17, 2021	Fulcrum Therapeutics, Inc.	Officer	Sell	45.0	-10,000	-1.94%	✓	$121.6K
Feb 16, 2021	Feb 18, 2021	Fulcrum Therapeutics, Inc.	Officer	Sell	45.0	-8,215	-1.57%	✓	$117.2K
Jan 20, 2021	Jan 22, 2021	Fulcrum Therapeutics, Inc.	Officer	Sell	45.0	-10,000	-1.87%	✓	$120.8K
Jul 8, 2020	Jul 9, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	48.8	-2,500	-0.47%	✓	$50K
Jun 25, 2020	Jun 26, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	48.8	-2,500	-0.46%	✓	$52K
Jun 9, 2020	Jun 10, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	58.8	-156	-0.03%	✓	$3.1K
Jun 5, 2020	Jun 9, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	47.5	-3,433	-0.63%	✓	$69.3K
Jun 3, 2020	Jun 5, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	47.5	-2,800	-0.51%	✓	$56.3K
Jun 1, 2020	Jun 3, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	47.5	-2,802	-0.51%	✓	$56K
May 28, 2020	Jun 1, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	47.5	-3,309	-0.60%	✓	$66.3K
May 26, 2020	May 28, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	48.8	-2,500	-0.45%	✓	$50K
Feb 19, 2020	Feb 20, 2020	Fulcrum Therapeutics, Inc.	Officer	Sell	48.8	-2,500	-0.45%	✓	$50K